SilenceMJD .: SilenceMJD - Silencing Machado Joseph Disease (Q2866753)

From EU Knowledge Graph
Revision as of 09:34, 13 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in de, and other parts: Adding German translations)
Jump to navigation Jump to search
Project Q2866753 in Portugal
Language Label Description Also known as
English
SilenceMJD .: SilenceMJD - Silencing Machado Joseph Disease
Project Q2866753 in Portugal

    Statements

    0 references
    42,500.0 Euro
    0 references
    50,000.0 Euro
    0 references
    85.0 percent
    0 references
    18 December 2019
    0 references
    17 December 2022
    0 references
    UNIVERSIDADE DE COIMBRA
    0 references
    Q2988597 (Deleted Item)
    0 references

    40°12'40.28"N, 8°25'46.06"W
    0 references
    Pretende-se com este projeto promover a transferência do conhecimento valorizando um ativo que pode dar origem a um produto inovador e de elevado valor acrescentado com especial aplicação na área da saúde para tratamento de uma doença neurodegenerativa através da proteção da tecnologia por patente. (Portuguese)
    0 references
    This project aims to promote the transfer of knowledge by valuing an asset that can give rise to an innovative and high added value product with special application in the area of health for the treatment of a neurodegenerative disease through the protection of technology by patent. (English)
    7 July 2021
    0 references
    Ce projet vise à promouvoir le transfert de connaissances en valorisant un atout qui peut donner naissance à un produit innovant à forte valeur ajoutée, avec une application particulière dans le domaine de la santé pour traiter une maladie neurodégénérative par la protection de la technologie par brevet. (French)
    4 December 2021
    0 references
    Dieses Projekt zielt darauf ab, den Wissenstransfer zu fördern, indem ein Gut bewertet wird, das zu einem innovativen Produkt mit hohem Mehrwert führen kann, das mit besonderer Anwendung im Bereich der Gesundheit zur Behandlung einer neurodegenerativen Krankheit durch Patentschutz führen kann. (German)
    13 December 2021
    0 references
    Coimbra
    0 references

    Identifiers

    CENTRO-01-0145-FEDER-046665
    0 references